ArticleHuman vaccines & immunotherapeutics2024
Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice.
Huijie Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.